Global Journal of Engineering and Technology Research (GJETR) · Research article · Open access

Design Standards and Regulatory Alignment for Vascular Access Devices in the United States: A Review of Design Control Requirements, Compliance Frameworks, And Opportunities for Scalable Safety-Driven Design Advancement

Oluwanifemi Olagunju

9 June 2026 · Vol. 2, Issue 6, pp. 175-188

DOI: 10.65150/EP-gjetr/V2E6/2026-03

Download full text (PDF)Cite this article

Abstract

Background: Vascular access devices (VADs) are ubiquitous in U.S. hospitals but carry risks of infection and thrombosis. U.S. regulations (FDA’s 21 CFR 820 and the new QMSR/ISO 13485 framework) mandate stringent design controls, yet their impact on clinical outcomes is unclear. Objective: To synthesize regulatory, engineering, and clinical evidence on VAD design and performance in the U.S. context and identify factors that enable or hinder safety-driven innovation. Methods: A narrative review of recent U.S.-focused literature was conducted, including FDA and CDC guidelines, regulatory notices, systematic reviews, randomized controlled trials, observational cohort studies, and quality improvement studies. Sources of literature included PubMed, Scopus, Google Scholar, and FDA/CDC publications from January 2010 to December 2025, with emphasis on evidence quality and applicability to U.S. practice. Key findings from the user’s manuscript were integrated and compared with this evidence. Results: The U.S. VAD regulatory framework (21 CFR 820, QMSR) incorporates international standards like ISO 13485, emphasizing design controls and risk management. However, high-quality studies do not consistently show that compliance with these processes alone reduces complications. In contrast, implementation of evidence-based insertion/maintenance bundles dramatically reduces central line-associated bloodstream infection (CLABSI) rates. Human factor gaps remain; FDA guidance stresses user-centered design to prevent use errors. Overall, evidence suggests that institutional practices (training, sterile technique, line care) often outweigh marginal design changes. Conclusions: Current U.S. device regulations provide a necessary framework but are insufficient by themselves to ensure safer VAD outcomes. We infer that integrating human-factors engineering, real-world outcome monitoring, and rigorous training is essential. Regulatory evolution (e.g., the QMSR’s 2026 implementation) should tie approval and post-market surveillance to clinical performance.

Keywords: Vascular access devices, FDA Quality Management System Regulation, CLABSI, Human factors engineering

Oluwanifemi Olagunju (2026). Design Standards and Regulatory Alignment for Vascular Access Devices in the United States: A Review of Design Control Requirements, Compliance Frameworks, And Opportunities for Scalable Safety-Driven Design Advancement. Global Journal of Engineering and Technology Research, 2(6), 175-188. https://doi.org/10.65150/EP-gjetr/V2E6/2026-03

@article{Oluwanifemi2026,
  title   = {Design Standards and Regulatory Alignment for Vascular Access Devices in the United States: A Review of Design Control Requirements, Compliance Frameworks, And Opportunities for Scalable Safety-Driven Design Advancement},
  author  = {Oluwanifemi Olagunju},
  journal = {Global Journal of Engineering and Technology Research},
  year    = {2026},
  volume  = {2},
  number  = {6},
  pages   = {175-188},
  doi     = {10.65150/EP-gjetr/V2E6/2026-03},
  url     = {https://doi.org/10.65150/EP-gjetr/V2E6/2026-03}
}

← All articlesAbout GJETR and how to submit